Air Liquide: Home Healthcare Acquisition in Colombia
January 24 2017 - 10:35AM
Business Wire
Regulatory News:
Air Liquide (Paris:AI) is expanding its home healthcare
business in South America with the acquisition of Oxymaster, a
national sector player in Colombia.
Present in the Colombian market for almost 20 years, Oxymaster
is specialized in home treatment and support for patients suffering
from respiratory conditions (sleep apnea, Chronic
Obstructive Pulmonary Disease, chronic respiratory failure).
Oxymaster has more than 240 employees and serves over
21,000 patients. The company generated revenues of
approximately €9 million in 2016.
South America's third-largest economy, Colombia enjoys
strong growth potential and has a robust healthcare system and
social welfare coverage reaching more than 90% of the
population. This acquisition, made via a majority equity stake,
marks Air Liquide's entry into a new territory with high
potential for its Healthcare activities. The Group will call on
the existing teams to continue developing the company's
business.
Air Liquide is already a major player in home healthcare in
South America, notably in Brazil, Argentina and Chile.
François Jackow, member of the Air Liquide Group’s
Executive Committee, supervising the Healthcare activities, said:
“Taking our Healthcare activities into Colombia allows us to
develop our business in South America in a growing market that
benefits from an advanced health system. The acquisition of
Oxymaster, recognized for its know-how in treatment of respiratory
diseases and the expertise of its teams, fits well with Air
Liquide's strategy of developing its Home Healthcare
activity.”
Air Liquide
Healthcaresupplies medical gases, home healthcare
services, hygiene products, medical equipment and specialty
ingredients. In 2015, it served over 7,500 hospitals and more than
1.3 million patients at home throughout the world. The Group's
Healthcare business reached €2,800 million in revenues in 2015,
with the support of 13,500 employees.
Air Liquide in ColombiaAir
Liquide announced its entry into the industrial gases market in
Colombia in 2016 to construct and operate a carbon dioxide unit and
a cogeneration unit, producing steam and electricity simultaneously
from natural gas and water, located approximately 40 kilometers
north of Bogotá.
The world leader in gases, technologies and services for
Industry and Health, Air Liquide is present in 80 countries with
approximately 68,000 employees and serves more than 3 million
customers and patients*. Oxygen, nitrogen and hydrogen are
essential small molecules for life, matter and energy. They embody
Air Liquide’s scientific territory and have been at the core of the
company’s activities since its creation in 1902.
Air Liquide’s ambition is to lead its industry, deliver
long-term performance and contribute to sustainability. The
company’s customer-centric transformation strategy aims at
profitable growth over the long term. It relies on operational
excellence, selective investments, open innovation and a network
organization implemented by the Group worldwide. Through the
commitment and inventiveness of its people, Air Liquide leverages
energy and environment transition, changes in healthcare and
digitization, and delivers greater value to all its
stakeholders.
Air Liquide’s revenues amounted to €16.4 billion in 2015, and
its solutions that protect life and the environment represented
more than 40% of sales. On 23 May 2016, Air Liquide completed its
acquisition of Airgas, which had revenues amounting to $5.3 billion
(around €4.8 billion) for the fiscal year ending 31 March 2016. Air
Liquide is listed on the Paris Euronext stock exchange (compartment
A) and belongs to the CAC 40 and Dow Jones Euro Stoxx 50
indexes.
* Following the acquisition of Airgas on 23 May 2016
www.airliquide.comFollow us on Twitter
@airliquidegroup
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170124005839/en/
Air LiquideCorporate CommunicationsCaroline
Brugier, +33 (0)1 40 62 50 59orAurélie Wayser-Langevin, +33 (0)1 40
62 56 19orInvestor RelationsParis+33 (0)1 40 62 50
87orRadnor+1 (0) 610 263 8277orAir Liquide Healthcare
CommunicationsCoralie Gazzeri, +33(0)1 49 69 45
40orCaribbean, Central America & Mexico
CommunicationsLiliana Rodriguez, +52 (81) 88 51 06 71
C3 AI (NYSE:AI)
Historical Stock Chart
From Jun 2024 to Jul 2024
C3 AI (NYSE:AI)
Historical Stock Chart
From Jul 2023 to Jul 2024